NYSE:AMRX

Amneal Pharmaceuticals Stock Insider Trading

Healthcare > Drug Manufacturers - Specialty & Generic

Buy AMRX

*Your capital is at risk

$16.11

-0.100 (-0.617%)

At Close: Jun 22, 2026

Amneal Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 60.88. In total, the insiders bought 8.28M and sold 1.75M AMRX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	60.88
● Buy	8.28M shares
● Sell	1.75M shares
74% Buy Activity Negligible or No Correlation
Buy Signal Medium Confidence Mar 03, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 60.88. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
May 11, 2026 Sell	Class A Common Stock S-Sale	Autor Deborah M. Director	Director	34 819 Value: $450.6K
May 07, 2026 Buy	Class A Common Stock M-Exempt	Autor Deborah M. Director	Director	34 819 Value: $477.7K
May 07, 2026 Buy	Class A Common Stock M-Exempt	Yanai Shlomo Director	Director	34 819 Value: $477.7K
May 07, 2026 Buy	Class A Common Stock M-Exempt	Patel Gautam Director	Director	34 819 Value: $477.7K
May 07, 2026 Buy	Restricted Stock Units M-Exempt	Patel Gautam Director	Director	34 819 Value: $477.7K
May 07, 2026 Buy	Class A Common Stock M-Exempt	Kiely John Director	Director	34 819 Value: $477.7K
May 07, 2026 Buy	Class A Common Stock M-Exempt	Nark Ted C Director	Director	34 819 Value: $477.7K
May 07, 2026 Buy	Class A Common Stock M-Exempt	Meister Paul M Director	Director	48 747 Value: $668.8K
May 07, 2026 Buy	Restricted Stock Units M-Exempt	Meister Paul M Director	Director	48 747 Value: $668.8K
May 07, 2026 Buy	Class A Common Stock M-Exempt	George Jeffrey P. Director	Director	34 819 Value: $477.7K
May 07, 2026 Buy	Restricted Stock Units M-Exempt	Autor Deborah M. Director	Director	34 819 Value: $477.7K
May 07, 2026 Buy	Restricted Stock Units M-Exempt	George Jeffrey P. Director	Director	34 819 Value: $477.7K
May 07, 2026 Buy	Restricted Stock Units M-Exempt	Yanai Shlomo Director	Director	34 819 Value: $477.7K
May 07, 2026 Buy	Class A Common Stock M-Exempt	Buchi J Kevin Director	Director	34 819 Value: $477.7K
May 07, 2026 Buy	Restricted Stock Units M-Exempt	Nark Ted C Director	Director	34 819 Value: $477.7K
May 07, 2026 Buy	Restricted Stock Units M-Exempt	Kiely John Director	Director	34 819 Value: $477.7K
May 07, 2026 Buy	Restricted Stock Units M-Exempt	Buchi J Kevin Director	Director	34 819 Value: $477.7K
May 06, 2026 Buy	Restricted Stock Units A-Award	Buchi J Kevin Director	Director	19 824 Value: $270.0K
May 06, 2026 Buy	Restricted Stock Units A-Award	Patel Gautam Director	Director	19 824 Value: $270.0K
May 06, 2026 Buy	Restricted Stock Units A-Award	Nark Ted C Director	Director	19 824 Value: $270.0K
May 06, 2026 Buy	Restricted Stock Units A-Award	Autor Deborah M. Director	Director	19 824 Value: $270.0K
May 06, 2026 Buy	Restricted Stock Units A-Award	George Jeffrey P. Director	Director	19 824 Value: $270.0K
May 06, 2026 Buy	Restricted Stock Units A-Award	Meister Paul M Director	Director	30 837 Value: $420.0K
May 06, 2026 Buy	Restricted Stock Units A-Award	Yanai Shlomo Director	Director	19 824 Value: $270.0K
May 06, 2026 Buy	Restricted Stock Units A-Award	Kiely John Director	Director	19 824 Value: $270.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT AMNEAL PHARMACEUTICALS, INC.

Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation produc...

Read Full Profile Here